Healthcare provider profile · identity verified

Bobby White, MD

Internal Medicine · NASHVILLE, TN · NPI 1073605499

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	621	174
Atorvastatin Calcium	Atorvastatin Calcium	503	137
Rosuvastatin Calcium	Rosuvastatin Calcium	400	115
Losartan Potassium	Losartan Potassium	366	95
Lisinopril	Lisinopril	364	97
Levothyroxine Sodium	Levothyroxine Sodium	333	84
Alprazolam	Alprazolam	296	64
Pantoprazole Sodium	Pantoprazole Sodium	274	84
Metformin Hcl Er	Metformin Hcl	240	68
Metoprolol Succinate	Metoprolol Succinate	215	61
Zolpidem Tartrate	Zolpidem Tartrate	211	47
Omeprazole	Omeprazole	207	55
Hydrochlorothiazide	Hydrochlorothiazide	191	51
Sertraline Hcl	Sertraline Hcl	181	50
Meloxicam	Meloxicam	169	50
Escitalopram Oxalate	Escitalopram Oxalate	160	45
Simvastatin	Simvastatin	141	42
Pravastatin Sodium	Pravastatin Sodium	134	34
Gabapentin	Gabapentin	132	39
Tamsulosin Hcl	Tamsulosin Hcl	120	35
Allopurinol	Allopurinol	119	31
Fluticasone Propionate	Fluticasone Propionate	111	38
Metoprolol Tartrate	Metoprolol Tartrate	106	31
Carvedilol	Carvedilol	102	27
Lorazepam	Lorazepam	99	15
Metformin Hcl	Metformin Hcl	97	27
Synthroid	Levothyroxine Sodium	96	24
Clopidogrel	Clopidogrel Bisulfate	92	25
Furosemide	Furosemide	89	27
Duloxetine Hcl	Duloxetine Hcl	88	26
Trazodone Hcl	Trazodone Hcl	82	27
Glimepiride	Glimepiride	80	25
Ozempic	Semaglutide	80	11
Citalopram Hbr	Citalopram Hydrobromide	79	20
Olmesartan Medoxomil	Olmesartan Medoxomil	78	24
Bupropion Xl	Bupropion Hcl	73	16
Fluoxetine Hcl	Fluoxetine Hcl	72	20
Atenolol	Atenolol	71	18
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	68	18
Mirtazapine	Mirtazapine	66	16
Albuterol Sulfate Hfa	Albuterol Sulfate	64	25
Diclofenac Sodium	Diclofenac Sodium	64	17
Buspirone Hcl	Buspirone Hcl	60	17
Celecoxib	Celecoxib	56	16
Clonazepam	Clonazepam	53	suppressed
Eliquis	Apixaban	53	15
Meclizine Hcl	Meclizine Hcl	53	17
Venlafaxine Hcl Er	Venlafaxine Hcl	53	11
Valacyclovir	Valacyclovir Hcl	52	19
Benazepril Hcl	Benazepril Hcl	51	12
Esomeprazole Magnesium	Esomeprazole Magnesium	50	17
Potassium Chloride	Potassium Chloride	48	18
Pregabalin	Pregabalin	47	suppressed
Spironolactone	Spironolactone	47	12
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	45	11
Montelukast Sodium	Montelukast Sodium	43	13
Tizanidine Hcl	Tizanidine Hcl	43	suppressed
Tramadol Hcl	Tramadol Hcl	43	13
Ondansetron Odt	Ondansetron	42	18
Memantine Hcl	Memantine Hcl	41	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	40	38
Amitriptyline Hcl	Amitriptyline Hcl	39	suppressed
Finasteride	Finasteride	39	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	37	18
Donepezil Hcl	Donepezil Hcl	36	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	35	11
Clonidine Hcl	Clonidine Hcl	34	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	33	suppressed
Lovastatin	Lovastatin	33	suppressed
Ezetimibe	Ezetimibe	32	suppressed
Paroxetine Hcl	Paroxetine Hcl	32	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	31	suppressed
Warfarin Sodium	Warfarin Sodium	30	suppressed
Hydrocortisone	Hydrocortisone	29	suppressed
Irbesartan	Irbesartan	29	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Jardiance	Empagliflozin	27	suppressed
Verapamil Er	Verapamil Hcl	27	suppressed
Famotidine	Famotidine	26	suppressed
Raloxifene Hcl	Raloxifene Hcl	26	suppressed
Nifedipine Er	Nifedipine	25	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	24	24
Dicyclomine Hcl	Dicyclomine Hcl	23	suppressed
Estradiol	Estradiol	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	20
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Valsartan	Valsartan	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	15
Bisoprolol Fumarate	Bisoprolol Fumarate	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Glipizide Er	Glipizide	20	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Methocarbamol	Methocarbamol	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Azelastine Hcl	Azelastine Hcl	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	17	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	16	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	suppressed
Diazepam	Diazepam	14	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	14	suppressed
Alendronate Sodium	Alendronate Sodium	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Triazolam	Triazolam	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Baclofen	Baclofen	12	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Methylprednisolone	Methylprednisolone	12	12
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	11	suppressed
Scopolamine	Scopolamine	11	suppressed
Xanax	Alprazolam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error